We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WALMEX:BMVWal-Mart de Mexico SAB de CV Analysis

Data as of 2026-08-17 - not real-time

MX$47.41

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Wal-Mart de México, S.A.B. de C.V. is bearish at MXN 47.41, with short-term averages lagging the long-term ones. Across the trailing 30 sessions it lost 5.1%. Relative strength is 38.8 — approaching oversold — and the MACD signal is bearish. Price has been bracketed by support at MXN 46.61 and resistance at MXN 50.86.
On valuation the read is fair — an earnings multiple of 16.4, absent a reliable peer benchmark. Consensus targets land 29.0% above where the shares trade now. The 4.24% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 21.7%, a beta of 0.28 and a maximum drawdown of 26.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

Seeking Alpha24dWal-Mart De Mexico S.A.B. de C.V. ADR WMMVY Q2 2026 Earnings Call Prepared Remarks TranscriptGood...Barron's1monWal-Mart de Mexico S.A.B. de C.V.About Wal-Mart de Mexico S.A.B. de C.V. Wal Mart de Mexico SAB de CV...The latest analyst revisions for Wal-Mart de México center on a reduced price target, with the average moving from...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 55.65
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 55.65
  • Analyst targets imply +29.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +29.0% versus the current price
  • P/E ratio of 16.4
  • Return on equity of 21.9%

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin4.90%
P/E Ratio16.4
ROE21.92%
ROA9.87%
Debt/Equity34.83
P/B Ratio3.4
Op. Cash FlowMX$88.6B
Free Cash FlowMX$22.5B

Technical Analysis

TrendBearish
RSI38.8
SupportMX$46.61
ResistanceMX$50.86
MA 20MX$48.79
MA 50MX$49.89
MA 200MX$55.65
MACDBearish
VolumeStable
Fear & Greed Index95.98

Valuation

Fair ValueMX$15.14
Target PriceMX$61.15
Upside/Downside28.98%
GradeFair
TypeValue
Dividend Yield4.24%

Risk Assessment

Beta0.28
Volatility21.70%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.